Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
4.800
+0.050 (1.05%)
At close: Aug 14, 2026, 4:00 PM EDT
4.752
-0.048 (-1.00%)
After-hours: Aug 14, 2026, 7:35 PM EDT
Relmada Therapeutics Employees
Relmada Therapeutics had 17 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,642,670
Market Cap
512.02M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 0 | - |
| Dec 31, 2024 | 17 | -3 | -15.00% |
| Dec 31, 2023 | 20 | 6 | 42.86% |
| Dec 31, 2022 | 14 | 4 | 40.00% |
| Dec 31, 2021 | 10 | -4 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MapLight Therapeutics | 133 |
| Kyverna Therapeutics | 129 |
| Adlai Nortye | 109 |
| C4 Therapeutics | 104 |
| OmniAb | 89 |
| Rezolute | 68 |
| Contineum Therapeutics | 51 |
| Zura Bio | 40 |
RLMD News
- 9 days ago - Relmada Therapeutics reports Q2 EPS (11c), consensus (20c) - TheFly
- 9 days ago - Relmada Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 9 days ago - Relmada Therapeutics Quarterly report: Q2 2026 - Filings
- 9 days ago - Relmada Therapeutics Earnings release: Q2 2026 - Filings
- 18 days ago - Relmada Therapeutics appoints Bipin Dalmia as chief business officer - TheFly
- 18 days ago - Relmada Therapeutics names Bipin Dalmia chief business officer - TheFly
- 18 days ago - Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer - GlobeNewsWire
- 4 weeks ago - Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - GlobeNewsWire